Protocol HNS 94-001 
REVISED 11/17/94 
Page 5 of 5 
study. Should contraception be interrupted or if there is any suspicion of pregnancy, 
my participation in this clinical research study will be terminal at e so 
discretion of the investigator. . , ~ n T 
14. 1 may discuss any questions or problems during or after this stu y wi r. ary 
Clayirtan at (713) 792-6920. In addition, I may discuss any problems I may have or 
anv questions regarding my rights during or after this study with the Chairman or t e 
Surveillance Committee at (713) 792-3220 and may in the event any problem arises 
during this clinical research contact the parties named above. 
CONSENT 
Based upon the above, I consent to participate in the research and have received a copy of 
the consent form. 
DATE 
SIGNATURE OF PARTICIPANT 
WITNESS OTHER THAN PHYSICIAN SIGNATURE OF PERSON 
OR INVESTIGATOR RESPONSIBLE & RELATIONSHIP 
I have discussed this clinical research study with the Participant and/or his or her authorized 
representative using a language which is understandable and appropriate. I believe that I 
have fully informed this participant of the nature of this study and its possible benefits and 
risks, and I believe the participant understood this explanation. 
PHYSICIAN/INVESTIGATOR 
( 666 ] 
Recombinant DNA Research, Volume 20 
